Get the Stockscreener App
80.26
1.52%
-1.24
Lemaitre Vascular Inc stock is traded at $80.26, with a volume of 209.05K.
It is down -1.52% in the last 24 hours and down -4.34% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$81.50
Open:
$81.39
24h Volume:
209.05K
Relative Volume:
0.93
Market Cap:
$1.78B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
43.86
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+1.98%
1M Performance:
-4.34%
6M Performance:
-23.01%
1Y Performance:
+5.61%
1-Day Range:
$80.03
$82.30
1-Week Range:
$78.01
$83.50
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
80.26 | 1.78B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Corton Capital Inc. Purchases New Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Tudor Investment Corp ET AL Purchases 20,597 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Comerica Bank - MarketBeat
Susquehanna Fundamental Investments LLC Buys Shares of 3,809 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Dimensional Fund Advisors LP Has $50.90 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by First Trust Advisors LP - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Up 4.2% Following Dividend Announcement - MarketBeat
Tower Research Capital LLC TRC Acquires 3,538 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Shares Down 5.4% After Earnings Miss - MarketBeat
Elutia Inc. Ends Distribution Agreement with LeMaitre - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - simplywall.st
LeMaitre Vascular (NASDAQ:LMAT) Shares Up 4.2% After Dividend Announcement - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year LowShould You Sell? - MarketBeat
Monashee Investment Management LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Voya Investment Management LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Q1 2025 Financial Results - ADVFN
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference | LMAT Stock News - GuruFocus
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference - The Manila Times
LeMaitre President Sets Stage for Major Healthcare Conference Presentation: Key Updates Expected - Stock Titan
Nebula Research & Development LLC Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Call Transcript - Insider Monkey
LeMaitre raises 2025 sales guidance to $245M amid strong Q1 growth and international expansion - MSN
Long Term Trading Analysis for (LMAT) - news.stocktradersdaily.com
LeMaitre Vascular, Inc. to Host Earnings Call - ACCESS Newswire
Why LeMaitre (LMAT) Shares Are Sliding Today - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
LeMaitre Vascular Reports Strong Q1 2025 Growth - TipRanks
LeMaitre Vascular Q1 2025 Earnings Call Transcript - MarketBeat
LeMaitre: Q1 Earnings Snapshot - MySA
Earnings call transcript: LeMaitre Vascular Q1 2025 reports solid growth, stock dips - Investing.com India
LeMaitre (LMAT) Surpasses Q1 Revenue Expectations and Raises Fut - GuruFocus
LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales - Yahoo Finance
LeMaitre (LMAT) Surpasses Q1 Revenue Expectations and Raises Future Sales Guidance | LMAT Stock News - GuruFocus
LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates - Yahoo Finance
LeMaitre Vascular Inc Reports Q1 2025 Earnings: Revenue Surpasse - GuruFocus
Earnings Flash (LMAT) LeMaitre Vascular Q1 EPS $0.48 vs. FactSet Est $0.50 - marketscreener.com
LeMaitre Q1 2025 Financial Results | LMAT Stock News - GuruFocus
(LMAT) Lemaitre Vascular Sees Fiscal Year 2025 Revenue $242M$249M - marketscreener.com
Earnings Flash (LMAT) Lemaitre Vascular Posts Q1 Revenue $59.9M, vs. FactSet Est of $57.6M - marketscreener.com
Marshall Wace LLP Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
LeMaitre Vascular (LMAT) to Release Quarterly Earnings on Thursday - MarketBeat
Earnings To Watch: LeMaitre (LMAT) Reports Q1 Results Tomorrow - Yahoo Finance
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):